drugset / Trial / NCT00664027
Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine the effects of three different doses of bardoxolone methyl administered orally on the kidney function (glomular filtration rate) in patients with diabetic nephropathy.
Timeline
- Start
- 2008-04-30
- Primary completion
- 2009-05-31
- Completion
- 2009-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bardoxolone methyl | Small molecule | 25 mg | Oral |
| Subject | Bardoxolone methyl | Small molecule | 75 mg | Oral |
| Subject | Bardoxolone methyl | Small molecule | 150 mg | Oral |